|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Reginal fat distribution and metabolism in a new mouse model (C57BIJ6) of non - insulin - dependent diabetes mel- litus 显示文摘 | Rebuffe - Scrive M Surwit R Feinglos M | 1993 | Metabolism1993，42，： | 1 |
| 2 | Regional Fat Distribution and Metabolism in a New Mouse Model (C57BL/ 6J) of Non-Insulin Dependent Diabetes Mellitus 显示文摘 | Rebuffe-Scrive M Surwit R Feinglos M | 1993 | Metabolism1993，42，11： | 1 |
| 3 | Effect of initial combination therapy with sitagliptin,adipeptidyl peptidase-4 inhibitor, and metformin on glycemiccontrol in patients with type 2 diabetes显示文摘 | GOLDSTEIN B J FEINGLOS M N LUNCEFORD J K etal | 2007 | Diabetes Care2007，30，8： | 1 |
| 4 | Effect of initial combination therapy with sitagliptin,a dipeptidyl peptidase-4 inhibitor,and metformin on glycemic control in patients with type 2 diabetes显示文摘 | GOLDSTEIN B J FEINGLOS M N LUNCEFORD J K | | 0，，08： | 1 |
| 5 | Oral agents in the management of type 2 diabetes mellitus显示文摘 | LUNA B FEINGLOS M N | 2001 | American Family Physician2001，63，9： | 1 |
| 6 | Differential effects of fat and sucrose on the development of obesity and diabetes in C57BL/6J and A/J mice显示文摘 | SURWIT R S FEINGLOS M N RODIN J | 1995 | Metabolism1995，44，： | 1 |
| 7 | Oral agent therapy in the treatment of type 2 diabetes 显示文摘 | Feinglos M N Bethel M A | 1999 | Diabetes Care1999，22，3： | 1 |
| 8 | Effects of liraglutide (NN2211),a long-acting GLP-1 analogue,on glycaemic control and bodyweight in subjects with type 2 diabetes显示文摘 | Feinglos M N | 2005 | Diabetic Medicine2005，22，83： | 1 |
| 9 | Gestational diabetes mellitus 显示文摘 | Setji T L Brown A J Feinglos M N | 2005 | Clinical Diabetes2005，23，1： | 1 |
| 10 | Update on type 2 diabetes mellitus:understanding changes in the diabetes treatment paradigm显示文摘 | Green J Feinglos M | | 0，，154： | 1 |
| 11 | Efficacy、safety and dose response characteristics of glipizide gastrointestinal therapeutic system on glycemic control and insulin secretion in NIDDM显示文摘 | Kourides IA Feinglos M | 1997 | Diabetes Care1997，20，： | 1 |
| 12 | Effects of exercise and weight loss on cardiac risk factors associated with syndrome X显示文摘 | Watkins LL Sherwood A Feinglos M | 2003 | Arch Intern Med2003，163，： | 1 |
| 13 | Efficacy, safety, and doseresponse characteristics of glipizide gastrointestinal the rapeutie system on glycemic control and insulin secretion in NIDDM显示文摘 | Simonson D C Kourides I A feinglos M | 1997 | Diabetes Care1997，20，7： | 1 |
| 14 | Effects of exercise and weight loss on cardiac risk factors associat- ed with syndrome X显示文摘 | Watkins LL Sherwood A Feinglos M | 2003 | Arch Intern Med2003，163，16： | 1 |
| 15 | Effect of initial combination therapy with sitagliptin, a dipeptidyl peptidase-4 inhibitor, and metformin on glyeemic control in patients with type 2 diabetes显示文摘 | Goldstein B Feinglos M Lunceford J | 2007 | Diabetes Care2007，30，： | 1 |
| 16 | Gestational diabetes mellitus显示文摘 | SETJI T L BROWN A J FEINGLOS M N | 2005 | Clinical Diabetes2005，23，1： | 1 |
| 17 | New combination treatments in the management of diabetes:focus on sitagliptin-metformin显示文摘 | Green J Feinglos M | 2008 | Vasc Health Risk Manag2008，4，4： | 1 |
| 18 | Effect of initial combination therapy with sitagliptin,a dipeptidyl peptidase-4 inhibitor,and metformin on glycemic control in patients with type 2 diabetes显示文摘 | GOLDSTEIN B J FEINGLOS M N LUNCEFORD J K | 2007 | Diabetes Care2007，30，8： | 1 |
| 19 | Efficacy safety and dose response characteristics of glipizide gastrointestinal therapeutic system on glycemic control and insulin secretion in NIDDM显示文摘 | Simson DC Kourides IA Feinglos M | 1997 | Diabetes Care1997，20，： | 1 |
| 20 | Effect of initial combination therapywith sitagliptin, a dipeptidyl pepti- dase- 4 inhibitor, and mefformin on glycemic control in pa- tients with type 2 diabetes 显示文摘 | Goldstein B J Feinglos M N Lunceford J K | 2007 | Diabetes Care2007，30，8： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员